Contact

All Stories

  1. Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial

    Article • The Lancet Healthy Longevity, June 2024, Elsevier

    Cécile MICHEL BULTEZ

  2. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

    Article • The Lancet Healthy Longevity, March 2024, Elsevier

    Cécile MICHEL BULTEZ

  3. Tumors: Oto-Rhino-Laryngology

    Article • January 2021, Springer Science + Business Media

    Cécile MICHEL BULTEZ

  4. Treatment of inoperable elderly head and neck cancer patients

    Article • Current Opinion in Oncology, May 2019, Wolters Kluwer Health

    Cécile MICHEL BULTEZ

  5. Head and Neck Tumors in Older Adults: Systemic Treatments and Combination with Local Strategies

    Article • January 2019, Springer Science + Business Media

    Cécile MICHEL BULTEZ

  6. Contribution of long-term dysphagia monitoring to first line treatment of head and neck cancer patients

    Article • International Journal of Otorhinolaryngology and Head and Neck Surgery, October 2018, Medip Academy

    Cécile MICHEL BULTEZ

  7. Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC

    Article • Future Oncology, March 2018, Future Medicine

    Cécile MICHEL BULTEZ

  8. Un programme de recherche français pour un traitement personnalisé des patients de plus de 70 ans atteints d’un cancer épidermoïde inopérable de la tête et du cou : les études ELAN ( elderly head and neck cancer )

    Article • Bulletin du Cancer, September 2017, Elsevier

    Cécile MICHEL BULTEZ

  9. Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance

    Article • Oral Oncology, May 2017, Elsevier

    Cécile MICHEL BULTEZ

  10. Validation multicentrique d’un questionnaire évaluant l’acceptation et la satisfaction des patients porteurs de chambre à cathéter implantable : le questionnaire QASICC

    Article • Bulletin du Cancer, April 2015, Elsevier

    Cécile MICHEL BULTEZ

  11. Reduced infections with perioperative immunonutrition in head and neck cancer: Exploratory results of a multicenter, prospective, randomized, double-blind study

    Article • Clinical Nutrition, October 2014, Elsevier

    Cécile MICHEL BULTEZ

  12. Patient Satisfaction with and Acceptance of Their Totally-Implanted Central Venous Catheter: Construction and First Validation of a Questionnaire

    Article • Journal of Cancer Therapy, January 2014, Scientific Research Publishing, Inc,

    Cécile MICHEL BULTEZ

  13. Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study

    Article • Journal of Chemotherapy, August 2012, Taylor & Francis

    Cécile MICHEL BULTEZ

  14. Cisplatin-Docetaxel Induction plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients: A Phase II Trial

    Article • Oncology, January 2012, Karger Publishers

    Cécile MICHEL BULTEZ

  15. Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study

    Article • Chemotherapy, January 2012, Karger Publishers

    Cécile MICHEL BULTEZ

  16. Sentinel Lymph Node Biopsy Prior to Neoadjuvant Chemotherapy: A Series of 89 Patients

    Article • Journal of Cancer Therapy, January 2012, Scientific Research Publishing, Inc,

    Cécile MICHEL BULTEZ

  17. A Phase I Study of UFT-Oral Vinorelbine in Metastatic Breast Cancer

    Article • Oncology, January 2011, Karger Publishers

    Cécile MICHEL BULTEZ